CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities:
Net loss	$ (43,980)	$ (13,549)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	28,149	28,263
Amortization	2,141	2,994
Straight-line rent adjustments	6	(886)
Amortization of deferred compensation	1,321	1,624
Paid-in-kind interest	11,514	0
Gain on hedge ineffectiveness	(1,303)	0
Gain on sales of interests in real estate and non-operating real estate, net	0	(1,916)
Equity in loss (income) of partnerships	3,433	(819)
Cash distributions from partnerships	0	845
Net change in other assets	18,805	11,674
Net change in other liabilities	(3,860)	(13,836)
Net cash provided by operating activities	16,226	14,394
Cash flows from investing activities:
Distribution of refinancing proceeds from equity method investee	0	8,003
Investments in real estate improvements	(1,928)	(2,414)
Additions to construction in progress	(1,029)	(20,157)
Investments in partnerships	(2)	(9,346)
Capitalized leasing costs	0	(164)
Additions to leasehold improvements and corporate fixed assets	(7)	(4,714)
Net cash used in investing activities	(2,966)	(28,792)
Cash flows from financing activities:
Net borrowings under the Restructured Revolver	0	34,000
Repayments of finance lease liabilities	(170)	(157)
Principal installments on mortgage loans	(9,505)	(3,475)
Payment of deferred financing costs	(253)	(212)
Value of shares of beneficial interest issued	0	424
Dividends paid to common shareholders	0	(16,492)
Dividends paid to preferred shareholders	0	(6,844)
Distributions paid to Operating Partnership unit holders and noncontrolling interest	0	(411)
Value of shares retired under equity incentive plans, net of shares issued	(647)	(466)
Net cash (used in) provided by financing activities	(10,575)	6,367
Net change in cash, cash equivalents, and restricted cash	2,685	(8,031)
Cash, cash equivalents, and restricted cash, beginning of period	51,231	19,629
Cash, cash equivalents, and restricted cash, end of period	$ 53,916	$ 11,598